9 янв. 2024 г. · Acromegaly is a rare, chronic disease caused by excessive secretion of growth hormone (GH), usually due to a pituitary somatotroph adenoma. |
This acromegaly guideline addresses important clinical issues regarding the evaluation and management of acromegaly, including the appropriate biochemical ... |
Endocrine Society guidelines and experts' consensus recommend using age- and sex-adjusted IGF-1 levels in combination with GH nadir during an oral glucose ... |
Because of the increased prevalence of colorectal adenomas and cancer, it is recommended that patients with acromegaly should be offered regular colonoscopy ... |
3 нояб. 2023 г. · In a patient with typical acromegaly features, insulin-like growth factor (IGF)-I > 1.3 times the upper limit of normal for age confirms the diagnosis. |
Treating acromegaly · reduce growth hormone production to normal levels · relieve the pressure a tumour may be putting on surrounding tissues · treat any hormone ... |
![PDF] Guidelines for acromegaly management: an update ...](imgx.php?https://figures.semanticscholar.org/8aa12d9dabbbe4ea93d193cf49cc5d669d5e8f15/6-Figure1-1.png)
3 сент. 2022 г. · Clinicians must measure serum IGF-1 levels as the best next step. In patients with a pituitary mass, screening for acromegaly may be warranted. |
9 июн. 2020 г. · Guidelines for the diagnosis and treatment of acromegaly have been released by the following organizations: Endocrine Society (ENDO) |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |